Cargando…

Factor associated with willingness to pay for prevention of cancer: a study of prostate cancer screening

INTRODUCTION: This study investigates Iranian men’s willingness to pay (WTP) for prostate cancer (PCa) screening and influencing factor, along with the impact of information. METHOD: We assessed preferences for prostate cancer screening in 771 Iranian men aged 40 and above using an internet-based qu...

Descripción completa

Detalles Bibliográficos
Autores principales: Farabi, Hiro, Moradi, Najmeh, Ahmadzadeh, Aziz, Agamir, Seyed Mohammad Kazem, Mohammadi, Abdolreza, Rezapour, Aziz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664311/
https://www.ncbi.nlm.nih.gov/pubmed/37990328
http://dx.doi.org/10.1186/s12962-023-00494-0
_version_ 1785148717368606720
author Farabi, Hiro
Moradi, Najmeh
Ahmadzadeh, Aziz
Agamir, Seyed Mohammad Kazem
Mohammadi, Abdolreza
Rezapour, Aziz
author_facet Farabi, Hiro
Moradi, Najmeh
Ahmadzadeh, Aziz
Agamir, Seyed Mohammad Kazem
Mohammadi, Abdolreza
Rezapour, Aziz
author_sort Farabi, Hiro
collection PubMed
description INTRODUCTION: This study investigates Iranian men’s willingness to pay (WTP) for prostate cancer (PCa) screening and influencing factor, along with the impact of information. METHOD: We assessed preferences for prostate cancer screening in 771 Iranian men aged 40 and above using an internet-based questionnaire survey. Participants received basic and complementary information, and their willingness to pay was determined through a payment card approach. A Wilcoxon test assessed the impact of information. We also analyzed prostate cancer screening demand and employed Heckman's two-step model to evaluate factors influencing the willingness to pay. Additionally, reasons for unwillingness to pay were explored. RESULTS: Willingness to pay significantly decreased with complementary information relative to basic information (16.3$ vs 17.8$). Heckman model, using WTP based on basic information shows age, education, and monthly household expenditure positively influenced the decision to pay. In contrast, health status, expectations of remaining life and prostate problems history positively affect amount of WTP for PCa screening, and insurance coverage has a negative impact on it. Majority of respondents (91%) supported PCa screening, with 82% expressing a willingness to pay. Common reasons for not paying include seeing screening as a public good (43%), financial constraints (35%), and having insurance (20%). The screening demand is price-sensitive. CONCLUSION: The basic mindset of Iranian men exaggerates the risk of prostate cancer. Reduced willingness to pay after receiving information reassures the reliability of their financial expectation. Taking into account the factors that influence PCa screening is essential for accurate planning and the successful implementation of this program.
format Online
Article
Text
id pubmed-10664311
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-106643112023-11-21 Factor associated with willingness to pay for prevention of cancer: a study of prostate cancer screening Farabi, Hiro Moradi, Najmeh Ahmadzadeh, Aziz Agamir, Seyed Mohammad Kazem Mohammadi, Abdolreza Rezapour, Aziz Cost Eff Resour Alloc Research INTRODUCTION: This study investigates Iranian men’s willingness to pay (WTP) for prostate cancer (PCa) screening and influencing factor, along with the impact of information. METHOD: We assessed preferences for prostate cancer screening in 771 Iranian men aged 40 and above using an internet-based questionnaire survey. Participants received basic and complementary information, and their willingness to pay was determined through a payment card approach. A Wilcoxon test assessed the impact of information. We also analyzed prostate cancer screening demand and employed Heckman's two-step model to evaluate factors influencing the willingness to pay. Additionally, reasons for unwillingness to pay were explored. RESULTS: Willingness to pay significantly decreased with complementary information relative to basic information (16.3$ vs 17.8$). Heckman model, using WTP based on basic information shows age, education, and monthly household expenditure positively influenced the decision to pay. In contrast, health status, expectations of remaining life and prostate problems history positively affect amount of WTP for PCa screening, and insurance coverage has a negative impact on it. Majority of respondents (91%) supported PCa screening, with 82% expressing a willingness to pay. Common reasons for not paying include seeing screening as a public good (43%), financial constraints (35%), and having insurance (20%). The screening demand is price-sensitive. CONCLUSION: The basic mindset of Iranian men exaggerates the risk of prostate cancer. Reduced willingness to pay after receiving information reassures the reliability of their financial expectation. Taking into account the factors that influence PCa screening is essential for accurate planning and the successful implementation of this program. BioMed Central 2023-11-21 /pmc/articles/PMC10664311/ /pubmed/37990328 http://dx.doi.org/10.1186/s12962-023-00494-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Farabi, Hiro
Moradi, Najmeh
Ahmadzadeh, Aziz
Agamir, Seyed Mohammad Kazem
Mohammadi, Abdolreza
Rezapour, Aziz
Factor associated with willingness to pay for prevention of cancer: a study of prostate cancer screening
title Factor associated with willingness to pay for prevention of cancer: a study of prostate cancer screening
title_full Factor associated with willingness to pay for prevention of cancer: a study of prostate cancer screening
title_fullStr Factor associated with willingness to pay for prevention of cancer: a study of prostate cancer screening
title_full_unstemmed Factor associated with willingness to pay for prevention of cancer: a study of prostate cancer screening
title_short Factor associated with willingness to pay for prevention of cancer: a study of prostate cancer screening
title_sort factor associated with willingness to pay for prevention of cancer: a study of prostate cancer screening
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664311/
https://www.ncbi.nlm.nih.gov/pubmed/37990328
http://dx.doi.org/10.1186/s12962-023-00494-0
work_keys_str_mv AT farabihiro factorassociatedwithwillingnesstopayforpreventionofcancerastudyofprostatecancerscreening
AT moradinajmeh factorassociatedwithwillingnesstopayforpreventionofcancerastudyofprostatecancerscreening
AT ahmadzadehaziz factorassociatedwithwillingnesstopayforpreventionofcancerastudyofprostatecancerscreening
AT agamirseyedmohammadkazem factorassociatedwithwillingnesstopayforpreventionofcancerastudyofprostatecancerscreening
AT mohammadiabdolreza factorassociatedwithwillingnesstopayforpreventionofcancerastudyofprostatecancerscreening
AT rezapouraziz factorassociatedwithwillingnesstopayforpreventionofcancerastudyofprostatecancerscreening